Embed, Don’t Disrupt: Scaling AI-Enabled Rare-Disease Diagnostics Within Clinical Workflows Globally
- Use software-first approaches that layers onto existing assays, instruments, databases, and tests to enable rare
- disease diagnostics without changing workflows
- Scale globally by design by deploying vendor-neutral integrations, localization, and strategic prioritization
- Leverage diagnostics across commercialization by aligning AI-enabled diagnostics with therapy launch and lifecycle including market access and patient services